California · 0053A

Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose in California

California Medicare Avg
$43.01
7% above national avg
National Medicare Avg
$40.38
All states combined
Billed Charge (CA)
$63.31
What providers submit
Est. Commercial (CA)
$103.23
National avg: $90.46
Est. Cash / Self-Pay (CA)
$49.67
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

54
Services in CA
27
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in California

Provider Medicare Services
Porterville Pharmacy Inc $41.47 21

California Pricing in Context

In California, CPT code 0053A (Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose) carries an average Medicare payment of $43.01 — 7% above the national benchmark of $40.38. 27 providers across the state submitted claims for this procedure in 2023, performing 54 total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in California is $63.31, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits above the national Medicare average, commercial rates in the state may also run higher than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Vaccines & Injections procedures, the estimated commercial insurance price in California lands near $103.23, with self-pay cash prices typically around $49.67. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose cost in California?

The average Medicare payment for Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose in California is $43.01, which is 7% above the national average of $40.38. Providers in CA typically bill $63.31 for this procedure.

What does Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose cost with insurance in California?

With commercial insurance in California, Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose costs an estimated $103.23. Without insurance, the estimated cash price is $49.67. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose in California?

27 providers in California billed Medicare for Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose in 2023, performing 54 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose cheaper in California than the national average?

No — Intramuscular Administration Of Single Severe Acute Respiratory Syndrome Coronavirus 2 (covid-19) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 30 Mcg/0.3ml Dosage, Tris-Sucrose Formulation; Third Dose costs 7% above the national average in California. The state average Medicare payment is $43.01 compared to $40.38 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial